In the wake of the Covid pandemic, the pace of change in healthcare has accelerated – and opportunity is plentiful. For innovators, change agents and forward-thinking investors in healthcare services, HI2 is a time to connect, learn, question, invest and help your company grow – in person.
HI2 Covid Protocols - Updated
1. Proof of Vaccination – Access to HI2 will be granted to all attendees who present official CDC-issued Proof of Vaccination (card, app, digital stamp, etc.).
2. Testing for Non-Vaccinated – For all attendees who are not vaccinated (or are unable to provide a certified proof of vaccination) HI2 will administer rapid antigen testing upon arrival. Access to the conference will be contingent upon a negative test result. (Attendees requiring testing should budget 30 to 45 minutes for processing time.)
3. On-site Safety Practices – HI2 will implement the following safety measures: temperature checks; distanced seating; and required masking.
4. Zero Tolerance. HI2 reserves the right to deny admission to, or remove, any person who does not comply with conference Covid protocols.
HI2 is designed to attract the best and brightest in healthcare – the most influential players driving change in healthcare, and the investors who are fueling that change. Two core audiences attend: growing healthcare service companies (disruptors, providers, payers and service companies) and private equity. The third group who is vital to HI2 is deal related services.
HI2 is the only conference exclusively serving growing healthcare service companies and private equity. There are others that have much broader audiences, others that only serve private equity, others that serve smaller innovators and venture capital, but only HI2 serves healthcare service companies and private equity.